Abstract
Although more than 30 anti-seizure medications are available on the market, epilepsy remains pharmaco-resistant in 30% of patients with focal epilepsy and approximately 10–15% of patients with idiopathic/genetic generalized epilepsy as well. The treatment of these complex patients needs a structured multidisciplinary approach to address the biological, social, and psychological implications. The current chapter is a general overview of epilepsy as a stigma, health, and financial problem and initiatives to change the conditions of patients with epilepsy. Special attention is focused on the effects of pharmacoresistant epilepsy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abou-Khalil BW. Update on Antiseizure medications 2022. Continuum. 2022;28:500–35. https://doi.org/10.1212/CON.0000000000001104.
Alva-Díaz C, Navarro-Flores A, et al. Prevalence and incidence of epilepsy in Latin America and the Caribbean: a systematic review and meta-analysis of population-based studies. Epilepsia. 2021;62:984–96. https://doi.org/10.1111/epi.16850.
Andersson K, Ozanne A, et al. Perceived stigma in adults with epilepsy in Sweden and associations with country of birth, socioeconomic status, and mental health. Epilepsy Behav. 2022;136:108886. https://doi.org/10.1016/j.yebeh.2022.108886.
Badawy RAB, Strigaro G, et al. TMS, cortical excitability and epilepsy: the clinical impact. Epilepsy Res. 2014;108:153–61. https://doi.org/10.1016/j.eplepsyres.2013.11.014.
Begley C, Wagner RG, et al. The global cost of epilepsy: a systematic review and extrapolation. Epilepsia. 2022;63:892–903. https://doi.org/10.1111/epi.17165.
Bou Nasif M, Koubeissi M, Azar NJ. Epilepsy - from mysticism to science. Rev Neurol. 2021;177:1047–58. https://doi.org/10.1016/j.neurol.2021.01.021.
Brigo F, Marson A. Approach to the medical treatment of epilepsy. Continuum. 2022;28:483–99. https://doi.org/10.1212/CON.0000000000001081.
Covanis A, Guekht A, et al. From global campaign to global commitment: The World Health Assembly’s Resolution on epilepsy. Epilepsia. 2015;56:1651–7. https://doi.org/10.1111/epi.13192.
Engel J, McDermott MP, Wiebe S, et al. Early Randomized Surgical Epilepsy Trial (ERSET) Study Group Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307:922–30. https://doi.org/10.1001/jama.2012.220.
Fallah A, Weil AG, et al. Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex. Epilepsy Behav. 2016;63:79–88. https://doi.org/10.1016/j.yebeh.2016.07.034.
Fisher RS, van Emde Boas W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470–2. https://doi.org/10.1111/j.0013-9580.2005.66104.x.
Fisher RS, Acevedo C, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475–82. https://doi.org/10.1111/epi.12550.
Gao L, Xia L, et al. Burden of epilepsy: a prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy. Epilepsy Res. 2015;110:146–56. https://doi.org/10.1016/j.eplepsyres.2014.12.001.
GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16:877–97. https://doi.org/10.1016/S1474-4422(17)30299-5.
Gesche J, Beier CP. Drug resistance in idiopathic generalized epilepsies: evidence and concepts. Epilepsia. 2022;63:3007–19. https://doi.org/10.1111/epi.17410.
Griffiths JG. A study of the Ba concept in ancient Egyptian texts. J Egypt Archaeol. 1970;56:227–8. https://doi.org/10.1177/030751337005600146.
Guekht A, Mizinova M, et al. The direct costs of epilepsy in Russia. A prospective cost-of-illness study from a single center in Moscow. Epilepsy Behav. 2016;64:122–6. https://doi.org/10.1016/j.yebeh.2016.08.031.
Guekht A, Brodie M, et al. The road to a World Health Organization global action plan on epilepsy and other neurological disorders. Epilepsia. 2021;62:1057–63. https://doi.org/10.1111/epi.16856.
Hohmann L, Berger J, et al. Perceived epilepsy-related stigma is linked to the socioeconomic status of the residence. Front Public Health. 2022;10:952585. https://doi.org/10.3389/fpubh.2022.952585.
Hong Z, Qu B, et al. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China. Epilepsia. 2009;50:2192–8. https://doi.org/10.1111/j.1528-1167.2009.02185.x.
Hughes JR. Dictator Perpetuus: Julius Caesar--did he have seizures? If so, what was the etiology? Epilepsy Behav. 2004;5:756–64. https://doi.org/10.1016/j.yebeh.2004.05.006.
ILAE Draft Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders (IGAP). The ILAE register. 2022. https://www.ilae.org. Accessed 09 Jan 2023.
Jetté N, Sander JW, et al. Surgical treatment for epilepsy: the potential gap between evidence and practice. Lancet Neurol. 2016;15:982–94. https://doi.org/10.1016/S1474-4422(16)30127-2.
Kaculini CM, Tate-Looney AJ, et al. The history of epilepsy: from ancient mystery to modern misconception. Cureus. 2021;13:e13953. https://doi.org/10.7759/cureus.13953.
Kalilani L, Faught E, et al. Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US. Neurology. 2019;92:e2197–208. https://doi.org/10.1212/WNL.0000000000007448.
Karakaş N, Sarıtaş SÇ, et al. Investigation of factors associated with stigma and social support in patients with epilepsy in Turkey: a cross-sectional study. Epilepsy Behav. 2022;128:108572. https://doi.org/10.1016/j.yebeh.2022.108572.
Khalil N, Benbadis S, et al. Ceasing antiquated conceptions: a telling of the early and evolving history of epilepsy. Eur Neurol. 2020;83:341–4. https://doi.org/10.1159/000509496.
Kitschen A, Aleknonytė-Resch M, Sakalytė G, Diederich F. Cost-effectiveness of surgical treatment compared to medical treatment in patients with drug-refractory epilepsy: a systematic review. Eur J Neurol. 2022;30:749. https://doi.org/10.1111/ene.15632. Epub ahead of print.
Kopciuch D, Barciszewska AM, et al. Economic and clinical evaluation of vagus nerve stimulation therapy. Acta Neurol Scand. 2019;140:244–51. https://doi.org/10.1111/ane.13137.
Kuramochi I, Iwayama T, et al. A study of factors influencing self-stigma in people with epilepsy: a nationwide online questionnaire survey in Japan. Epilepsia Open. 2022;7:792–801. https://doi.org/10.1002/epi4.12661.
Kwan P, Arzimanoglou A, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069–77. https://doi.org/10.1111/j.1528-1167.2009.02397.x.
Lalatović S, Milovanović M, et al. Stigma and its association with health-related quality of life in adults with epilepsy. Epilepsy Behav. 2022;135:108874. https://doi.org/10.1016/j.yebeh.2022.108874.
Langfitt JT, Holloway RG, et al. Health care costs decline after successful epilepsy surgery. Neurology. 2007;68:1290–8. https://doi.org/10.1212/01.wnl.0000259550.87773.3d.
Lee SA, Korean QoL in Epilepsy Study Group, et al. Dual burdens of felt stigma and depressive symptoms in patients with epilepsy: their association with social anxiety, marriage, and employment. Epilepsy Behav. 2022;134:108782. https://doi.org/10.1016/j.yebeh.2022.108782.
Levira F, Epidemiology Commission of the International League Against Epilepsy, et al. Premature mortality of epilepsy in low- and middle-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia. 2017;58:6–16. https://doi.org/10.1111/epi.13603.
Malik NI, Fatima R, et al. Perceived stigma, discrimination and psychological problems among patients with epilepsy. Front Psych. 2022;13:1000870. https://doi.org/10.3389/fpsyt.2022.1000870.
Mameniškienė R, Puteikis K, Carrizosa-Moog J. Saints, demons, and faith - a review of the historical interaction between Christianity and epilepsy. Epilepsy Behav. 2022;135:108870. https://doi.org/10.1016/j.yebeh.2022.108870.
Megiddo I, Colson A, et al. Health and economic benefits of public financing of epilepsy treatment in India: an agent-based simulation model. Epilepsia. 2016;57:464–74. https://doi.org/10.1111/epi.13294.
Myanmar epilepsy initiative: piloting the WHO programme on reducing the epilepsy treatment gap 2013–2017 myanmar-epilepsy-initiative.pdf (who.int). 2018. Accessed 11 Jan 2023.
Newton CR, Garcia HH. Epilepsy in poor regions of the world. Lancet. 2012;380:1193–201. https://doi.org/10.1016/S0140-6736(12)61381-6.
Nicastro N, Picard F. Joan of Arc: sanctity, witchcraft or epilepsy? Epilepsy Behav. 2016;57:247–50. https://doi.org/10.1016/j.yebeh.2015.12.043.
Radhakrishnan K. Challenges in the management of epilepsy in resource-poor countries. Nat Rev Neurol. 2009;5:323–30. https://doi.org/10.1038/nrneurol.2009.53.
Servilha-Menezes G, Garcia-Cairasco N. A complex systems view on the current hypotheses of epilepsy pharmacoresistance. Epilepsia Open. 2022;7(Suppl 1):S8–S22. https://doi.org/10.1002/epi4.12588.
Tényi D, Gyimesi C, et al. The possible role of the insula in the epilepsy and the gambling disorder of Fyodor Dostoyevsky. J Behav Addict. 2016;5:542–7. https://doi.org/10.1556/2006.5.2016.061.
Thurman DJ, Hesdorffer DC, et al. Sudden unexpected death in epilepsy: assessing the public health burden. Epilepsia. 2014;55:1479–85. https://doi.org/10.1111/epi.12666.
Vanzan A, Paladin F. Epilepsy and Persian culture: an overview. Epilepsia. 1992;33:1057–64. https://doi.org/10.1111/j.1528-1157.1992.tb01759.x.
Walther K, Kriwy P, Stritzelberger J, et al. Attitudes towards persons with epilepsy as friends: results of a factorial survey. Epilepsia. 2022; https://doi.org/10.1111/epi.17491.
WHO Epilepsy: a public health imperative. The WHO register. 2019. https://www.who.int. Accessed 11 Jan 2023.
WHO-Epilepsy-Ghana_web.pdf. n.d. Accesed 11 Jan 2023.
Wiebe S, Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group, et al. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311–8. https://doi.org/10.1056/NEJM200108023450501.
Wimo A, Guerchet M, et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. 2017;13:1–7. https://doi.org/10.1016/j.jalz.2016.07.150.
Zarrelli MM, Beghi E, et al. Incidence of epileptic syndromes in Rochester, Minnesota: 1980-1984. Epilepsia. 1999;40:1708–14. https://doi.org/10.1111/j.1528-1157.1999.tb01587.x.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
San-Juan, D., Peralta, R.A.C. (2023). Pharmacoresistance in Epilepsy. In: Rocha, L.L., Lazarowski, A., Cavalheiro, E.A. (eds) Pharmacoresistance in Epilepsy. Springer, Cham. https://doi.org/10.1007/978-3-031-36526-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-36526-3_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-36525-6
Online ISBN: 978-3-031-36526-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)